Mirion Technologies

Mirion Technologies, Inc. engages in the provision of nuclear measurement and detection systems. It offers measurement and enterprise, calibration, customer training programs, installation, product support and repairs, consulting, and instadose desimetry services. The company was founded by Thomas D. Logan in December 2005 and is headquartered in Atlanta, GA.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Mirion Technologies posts robust Q4 earnings, eyes SMR market growth

Mirion Technologies reported strong financials, with double-digit revenue growth and a focus on reducing leverage, despite challenges like supply chain issues.
The company's strategic focus on the Medical and Industrial segments, along with opportunities in the SMR market, bode well for future growth.
Balanced growth strategies, disciplined capital allocation, and engagement in key markets position Mirion Technologies for continued success in 2023.

Mirion Technologies reports robust Q1 earnings, eyes growth opportunities

Mirion Technologies delivered strong Q1 results, focusing on operational efficiency, margin improvement, and cash flow generation. The company's rebranding efforts and positive market outlook position it well for future growth. With a history of margin expansion and free cash flow conversion, Mirion is poised for continued success in 2023.

Mirion Technologies posts robust Q2 results and eyes growth opportunities

Mirion Technologies delivered strong Q2 results with positive revenue growth and operational performance.
The company's focus on margin improvement and order intake positions it well for future success.
Despite challenges in pricing dynamics and cash flow, Mirion Technologies remains optimistic about its outlook.

Mirion Technologies excels in Q3 with strong order growth and record backlog

Mirion Technologies delivered a strong Q3 performance with significant order growth and record backlog, supported by strategic acquisitions and operational focus.
While facing challenges in organic growth and margin maintenance, the company remains optimistic about future opportunities for revenue expansion and profitability.
Maintaining financial targets, optimizing cash flow, and emphasizing margin expansion are key priorities for sustained success and market leadership.

Mirion Technologies reports record 2023 results and bullish 2024 guidance

Mirion Technologies had a stellar 2023, setting records in revenue, EBITDA, and free cash flow, with strong guidance for 2024.
The company is strategically focused on margin expansion, cost control, and product innovation to drive future growth.
While facing challenges in healthcare reimbursement and cost management, Mirion is leveraging international markets and new product introductions.
Confidence in achieving growth targets, Mirion remains committed to operational excellence and enhancing shareholder value.

Mirion Technologies reports solid Q1 performance, eyes growth opportunities

Mirion Technologies demonstrated strong financial performance in Q1 2024, driven by key growth drivers in nuclear power and cancer care. Despite challenges in cash flow and margin pressure, the company remains focused on growth opportunities through innovation and strategic initiatives.

Mirion Technologies reports solid Q2 results, eyes growth opportunities

Mirion Technologies showcased solid performance with margin exceeding expectations and raised EBITDA guidance. While facing tough order growth comps, the company is focused on driving organic growth and improving cost structure. Anticipated improvements in Chinese market dynamics and potential positive impact from upcoming CMS changes present growth opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Mirion Technologies, Inc. engages in the provision of radiation safety, science, and medicine. It operates through the Medical and Technologies segments. The Medical segment consists of sales, products, and services to customers in the medical market. The Technologies segment involves nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. The company was founded by Thomas D. Logan in December 2005 and is headquartered in Atlanta, GA.

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for the fourth quarter and full year 2023 after market close on Tuesday, February 13, 2024. Following the news release, the company will host a conference call the next day, Wednesday, February 14, 2024, at 10:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live web.

Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2023

I invested in Mirion during a time when the sentiment was low, but the thesis was simple. Mirion's products have a crucial role in the nuclear industry and have minimal downside risk. Its addressable market is growing and its products have a moat. Through a combination of acquisitions and organic growth the company has been seeing consistent growth in its topline.

Mirion Technologies: A Good Way To Diversify Uranium Sector Exposure

ATLANTA--(BUSINESS WIRE)--Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced an agreement with nuclear innovation company TerraPower to design and fabricate key components of their Molten Chloride Reactor Experiment (MCRE), the world's first critical fast-spectrum salt reactor. This collaboration reinforces TerraPower and Mirion's commitment to fostering sustainable, low-carbon energy solutions that address climate change and support a ne.

Mirion Technologies Signs Agreement with TerraPower for Molten Chloride Reactor Experiment

Mirion Technologies, Inc. (NYSE:MIR ) Q3 2023 Results Conference Call November 2, 2023 12:00 PM ET Company Participants Alex Gaddy - SVP, Strategy Larry Kingsley - Chairman Tom Logan - CEO Brian Schopfer - CFO Conference Call Participants Joe Ritchie - Goldman Sachs Andy Kaplowitz - Citi Group Chris Moore - CJS Securities Operator Greetings, and welcome to the Mirion Third Quarter 2023 Earnings Conference Call. [Operator Instructions].

Mirion Technologies, Inc. (MIR) Q3 2023 Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--Mirion ("we" or the "company") (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the third quarter ended September 30, 2023. Related materials will be available online at ir.mirion.com. On November 1, 2023, Mirion also closed the acquisition of ec2, with a purchase price of $33 million through an all cash purchase. “This was an exc.

Mirion Announces Third Quarter 2023 Financial Results and Reiterates Full Year Guidance

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced a philanthropic partnership with RAD-AID International to help bring radiology and radiation safety education and capabilities to underserved populations around the world. RAD-AID works to establish sustainable radiology programs in low-resources areas, training local health professionals and equipping them with the necessary tools and knowledge to deliver effective care. Wit.

Mirion Launches Philanthropic Partnership with RAD-AID International

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the Baird Global Industrial Conference in Chicago, IL. The presentation will begin at 10:40 AM ET on Tuesday, November 7, 2023. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of the webcast will be available at the sa.

Mirion to Present at the Baird Global Industrial Conference

ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that Michael Rossi has informed the Company of his decision to resign as Medical Group President, effective November 1, 2023, in order to assume a CEO role at another public company. Mirion's Chief Executive Officer, Thomas Logan, will reassume the responsibilitie.

Mirion Announces Departure of Medical Group President

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for the third quarter of 2023 after market close on Wednesday, November 1, 2023. Following the news release, the company will host a conference call the next day, Thursday, November 2, 2023, at 12:00 pm ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will als.

Mirion Announces Earnings Release and Conference Call Date for Third Quarter 2023

ATLANTA--(BUSINESS WIRE)--Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced its contribution to the Psyche mission, which launched from the agency's Kennedy Space Center in Florida on October 13, 2023. A long-time contributor to space exploration and other big-science applications, Mirion has provided a specialized high-purity germanium (HPGe) gamma-ray detection component that will play a pivotal role in unlocking the mysteries of the a.

Mirion Technologies Gamma Detector to Play Crucial Role in NASA's Psyche Mission

SunCHECK® Platform Enhancements, New MRgRT QA Solutions, and More MELBOURNE, Fla. , Sept. 29, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (NYSE: MIR), will showcase enhancements and additions to its comprehensive Quality Management portfolio at the ASTRO Annual Meeting, October 1-3, in San Diego, California.

Sun Nuclear® Solutions Supporting Better Patient Care in Focus at ASTRO 2023

Faster, Hyper-Accurate Commissioning and Beam Scanning Solution Now Available in Countries Requiring CE Marking MELBOURNE, Fla. , Sept. 28, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (NYSE: MIR), today announced achievement of the CE mark per EU Medical Device Regulation for the SunSCAN™ 3D cylindrical water scanning system.

Sun Nuclear SunSCAN™ 3D Water Scanning System Receives CE Marking

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chief Financial Officer, Brian Schopfer, will present at the Jefferies Industrials Conference in New York, NY. The presentation will begin at 9:00 AM ET on Wednesday, September 6, 2023. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of the webcast will be available at the same location within twelve hours of the con.

Mirion to Present at the Jefferies Industrials Conference

Mirion Technologies is a radiation detection and monitoring company with a market cap of $1.6 billion. Both the Medical and Industrial segments of the company outperformed market expectations in terms of revenue. But the bottom line is still negative. Mirion is expected to launch the third generation of Instadose technology in FY2024, which should contribute to its growth.

Mirion Technologies: Wait When The Targets Are Met

ATLANTA--(BUSINESS WIRE)--Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced a strategic design contract with X-Energy Reactor Company, LLC (“X-energy”), a leading developer of advanced small modular nuclear reactors and fuel technology for clean energy generation. Per the agreement, Mirion will provide detailed design support for the Burn Up Measurement System (BUMS), a vital system for the fuel cycle of the Xe-100 high-temperature gas-c.

Mirion Technologies Awarded Strategic Design Contract for X-energy's Small Modular Reactor

Mirion Technologies, Inc. (NYSE:MIR ) Q2 2023 Earnings Conference Call August 2, 2023 12:00 PM ET Company Participants Alex Gaddy - VP, IR Lawrence Kingsley - Chairman Thomas Logan - Founder, CEO & Director Brian Schopfer - CFO Conference Call Participants Joseph Ritchie - Goldman Sachs Group Christopher Moore - CJS Securities Operator Greetings, and welcome to the Mirion Technologies Second Quarter 2023 Earnings Conference Call. [Operator Instructions].

Mirion Technologies, Inc. (MIR) Q2 2023 Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--Mirion ("we" or the "company") (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the second quarter ended June 30, 2023. “We posted strong second quarter results, headlined by our fourth consecutive quarter of backlog expansion and solid revenue growth in both reporting segments,” stated Thomas Logan, Mirion's Chief Executive Offic.

Mirion Announces Second Quarter 2023 Financial Results and Updates Full Year Guidance

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for the second quarter of 2023 on Wednesday, August 2, 2023. Following the news release, the company will host a conference call the same day at 12:00 pm ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-even.

Mirion Announces Earnings Release and Conference Call Date for Second Quarter 2023

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it has published its inaugural Corporate Social Responsibility Report, detailing the company's focus and commitment to advancing along its corporate citizenship journey. “Mirion is committed to having a positive impact on the world through our operations. This is exemplified by our company's mission of harnessing our unrivaled knowledge of ionizing radiation for the greater good of humanity,” said Thomas Logan, Mirion's Chief Exe.

Mirion Releases Inaugural Corporate Social Responsibility Report

ATLANTA--(BUSINESS WIRE)--Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced a major update of the company's flagship Genie spectroscopy software. With the release of Genie 4.0 software, Mirion builds upon nearly 40 years of leadership in spectroscopy solutions and services, delivering a range of new features that enhance efficiency and accuracy for both existing and new users, while introducing simplified software models and flexible pur.

Mirion Technologies Introduces Genie™ 4.0 Spectroscopy Software, Now with Flexible Licensing Options

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will present at the Jefferies Healthcare Conference in New York, NY. The presentation will begin at 11:30 AM ET on Wednesday, June 7, 2023. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of the webcast will be available at the same location within twelve hours of the conclusion.

Mirion to Present at the Jefferies Healthcare Conference

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the pricing of an underwritten public offering of 7,000,000 shares of Mirion's Class A common stock by certain selling stockholders at a price to the public of $7.65 per share. Selling stockholders participating in the offering consist.

Mirion Technologies Announces Pricing of Public Offering by Selling Stockholders

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the commencement of an underwritten public offering of 7,000,000 shares of Mirion's Class A common stock by certain selling stockholders. Selling stockholders participating in the offering consist of entities affiliated with Charterhou.

Mirion Technologies Announces Proposed Public Offering by Selling Stockholders

Mirion Technologies, Inc. (NYSE:MIR ) Q1 2023 Earnings Conference Call May 3, 2023 12:00 PM ET Company Participants Alex Gaddy - Vice President, Finance Larry Kingsley - Chairman Tom Logan - Chief Executive Officer Brian Schopfer - Chief Financial Officer Conference Call Participants Chris Moore - CJS Securities Andy Kaplowitz - Citigroup Joe Ritchie - Goldman Sachs Operator Greetings and welcome to the Mirion First Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

Mirion Technologies, Inc. (MIR) Q1 2023 Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--Mirion ("we" or the "company") (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the first quarter ended March 31, 2023. During the first quarter, Mirion received a $150 million direct at-the-market investment and utilized $125 million for debt repayment. This helped the company bring net leverage down during the quarter. The compa.

News for Mirion Technologies Stock (MIR)